LAWRENCE, Mass., April 27, 2011 /PRNewswire via COMTEX/ —
NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Michael Miller, Jr., former Senior Vice President and General Manager of the Cardiac Care Business at Philips Healthcare, has joined the NxStage senior management team in the newly-created position of President, International.
Miller will be responsible for advancing the Company’s international growth plans in the European Union (EU), the Middle East, and Asia-Pacific. I believe NxStage has a tremendous opportunity to expand patient access to its life-changing products across the globe, said Miller. This is a remarkable company that I believe has the potential to truly transform renal care on an even broader scale. I am excited to join NxStage and to bring my experience in international medical device sales and business development to its important mission.
During ten years at Philips, Miller held leadership roles in marketing and general management for a variety of global businesses. In his most recent role as Senior Vice President and General Manager of the Philips Cardiac Care Business he led worldwide expansion efforts for four medical device businesses across new and emerging markets. Prior to Philips, Miller was Director and Vice President of U.S. Sales for Advanced Sterilization Products, a division of Johnson & Johnson Medical, Inc., as well as Director of International and New Business Development- Worldwide. He also held various positions with Hewlett Packard Medical Products Group that included responsibilities for domestic and international product marketing in several product areas. Miller holds an MBA from Harvard Graduate School of Business Administration and a BA in economics from Yale University.
Mike’s strong track record in global sales over three decades for some of the premier leaders in our industry speaks for itself, said Jeffrey Burbank, Chief Executive Officer of NxStage Medical, Inc. NxStage is very pleased that such a proven leader shares our vision and excitement to make a life-changing difference in renal care for patients with ESRD. I believe Mike’s skills and experience will be invaluable to us as we advance our international expansion strategy.
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company’s website at www.nxstage.com.
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words anticipate, believe, expect, estimate, plan, and similar expressions are generally intended to identify forward-looking statements. The forward-looking statements in this release include statements as to NxStage’s ability to expand patient access to its products worldwide and NxStage’s ability to transform renal care worldwide. Results may differ materially from those indicated by these forward-looking statements as a result of various important factors including customer demand for our products in the European Union (EU), the Middle East and Asia-Pacific and other factors that are discussed in NxStage’s Annual Report on Form 10-K for the year ended December 31, 2010 filed with the SEC. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
Kristen Sheppard, Esq.
Vice President, Investor Relations
NxStage Medical, Inc.
SOURCE NxStage Medical, Inc.